Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “BOARD OF REGENTS”

2,639 pharma patents match "BOARD OF REGENTS" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,639
Index total 30,257
Page 76 / 110

Quick answer

This filtered view shows 2,639 pharmaceutical patents matching "BOARD OF REGENTS" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,639 results for “BOARD OF REGENTS” · 30,257 patents in full index Clear search

  1. US 8298542

    Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of Chlamydia

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  2. US 8299040

    Methods for treating cancer targeting transglutaminase

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  3. US 8298589

    Nitrite formulations and their use as nitric oxide prodrugs

    The Board of Regents of the University of Texas System · Granted Oct 30, 2012 · Expires Oct 25, 2032

    granted

  4. US 8283114

    Genes of an otitis media isolate of nontypeable Haemophilus influenzae

    The Board of Regents of the University of Oklahoma · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  5. US 8283458

    VMP-like sequences of pathogenic Borrelia species and strains

    The Board of Regents of the University of Texas System · Granted Oct 9, 2012 · Expires Oct 4, 2032

    granted

  6. US 8273729

    Treatment of irritable bowel syndrome and related bowel disease

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  7. US 8273746

    Methods involving aldose reductase inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 25, 2012 · Expires Sep 20, 2032

    granted

  8. US 8268825

    Method for the treatment of anthrax infections

    The Board of Regents for Oklahoma State University · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  9. US 8268849

    Multifunctional Antioxidants and methods of use thereof

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Sep 18, 2012 · Expires Sep 13, 2032

    granted

  10. US 8258163

    Small-molecule agonists for type-2 orexin receptor

    The Board of Regents of the University of Texas System · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  11. US 8258274

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Sep 4, 2012 · Expires Aug 30, 2032

    granted

  12. US 8252807

    Methods of inhibiting the interaction between S100 and the receptor for advanced glycation end-products

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  13. US 8252836

    Preparations of phospholipids and pharmaceuticals containing 5-amino salicylic acid for the treatment of inflammatory bowel disease

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  14. US 8252574

    Pseudoinfectious flavivirus and uses thereof

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  15. US 8252841

    Methods of inhibiting bacterial virulence and compounds relating thereto

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  16. US 8252764

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted Aug 28, 2012 · Expires Aug 23, 2032

    granted

  17. US 8236279

    Bisaminoethanethiol-targeting ligand conjugates and compositions

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  18. US 8236983

    Composition and method for the treatment of diseases affected by apoptosis

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted

  19. US 8232068

    Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays

    The Board of Regents of the University of Texas System · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

  20. US 8227583

    Vaccines containing canine parvovirus genetic variants

    The Board of Regents for Oklahoma State University · Granted Jul 24, 2012 · Expires Jul 19, 2032

    granted

  21. US 8216593

    Parasite vaccine

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  22. US 8216614

    Powder mix of potassium calcium citrate for the treatment of kidney stones and osteoporosis

    The Board of Regents of the University of Texas System · Granted Jul 10, 2012 · Expires Jul 5, 2032

    granted

  23. US 8211635

    P53 modulator and cancer target

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

  24. US 8211941

    Antagonists of the transient receptor potential vanilloid 1 and uses thereof

    The Board of Regents of the University of Texas System · Granted Jul 3, 2012 · Expires Jun 28, 2032

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.